Targeted cancer therapies are the latest advances. Cancer is the second leading cause of death in the United States. Cancer survivorship rates have increased drastically, with approximately 73 percent of survival gains in cancer attributable to new medicines.
America’s biopharmaceutical research companies are responding to the needs of cancer patients, working to develop more effective and better tolerated treatments.
Researchers are now exploring game-changing methods and technologies to fight cancer as well as innovative ways to use existing medicines, either alone or in combination with other therapies.
Oncology research Ted Johnson, who works for Pfizer in San Diego, concentrates on lung cancer.
In the interview below, he describes targeted therapies.
The website in the interview is GOBODLY.COM
Photo Credit: Getty Images